Between January and March 2019, Russia imported 2.6 bln RUB worth of pharmaceuticals made in the EEU countries (wholesale prices, VAT included), which is in monetary terms 49.6% higher than that of the same period in 2018. The dynamics in physical terms are +61.2% (65.3 mln units).

Over the period, Russia more often imported pharmaceutical drugs in smaller dosage forms. If calculated in minimum dosage units (MDU), the dynamics are nearly +34%. This trend is not true for the whole import line, for example, in 2019 Russia has been more often importing Sodium Chloride (100, 200, and 250 ml) in 1-dose unit form than in 30-, 40-, and 120-dose unit forms.

However, the import line has lost 11 trademarks and is now comprised of 88. Among the pharmaceuticals that are no longer imported, Protamin-Insulinum by Alvils used to contribute to the dynamics the most. The dynamics of Alvils in monetary terms are -83%.
Heparin by Belmedpreparaty has the highest import volume in monetary terms, +27%. Sodium Chloride by Kelun-Kazpharm (Kazakhstan) and by Borisov Plant of Medical preparations (Belarus) follows, its import has grown by 7.6 times. Ceftriaxone comes third with a 2.8 times increase. It was imported by Belmedpreparaty and Borisov Plant of Medical preparations.